Karl Bedke

Karl Bedke has worked as a Principal Scientist at Vividion Therapeutics since January 2020. Before that, they were a Scientist II at Peloton Therapeutics from August 2017 to January 2020. From July 2011 to July 2017, they worked as a Scientist at Amgen.

Karl Bedke obtained their Bachelor of Science (B.S.) degree in Chemistry from Brigham Young University between 1999 and 2006. Later, they pursued a Doctor of Philosophy (Ph.D.) degree in Organic Chemistry from UC Irvine, completing their studies between 2006 and 2011.